| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.lotuseye.org | |
| Market Cap | 152.06 Cr. | |
| Enterprise Value(EV) | 143.65 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.96 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 37.30 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 48.14 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 27.69 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 2.64 | Calculated using Price: 73.12 |
| Dividend Yield | 0.68 | Period Ending 2022-03 |
| No. of Shares Subscribed | 2.08 Cr. | 20,796,330 Shares |
| FaceValue | 10 | |
| About Lotus Eye Hospital And Institute Ltd. | ||
| Lotus Eye Care Hospital was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.'on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited' upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore. | ||
| 1 Day |
|
-1.18% |
| 1 Week |
|
+1.65% |
| 1 Month |
|
+4.76% |
| 3 Month |
|
+13.38% |
| 6 Month |
|
-21.67% |
| 1 Year |
|
+49.53% |
| 2 Year |
|
+60.0% |
| 5 Year |
|
+158.83% |
| 10 Year |
|
+1024.92% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 0.08 | -3.93 | 0.20 | 0.89 | 3.47 | 1.41 | 2.10 | 3.02 | 5.56 | |
| Return on Capital Employed (%) | 0.27 | -4.14 | 0.27 | 1.13 | 3.71 | 1.66 | 3.32 | 4.07 | 8.00 | |
| Return on Assets (%) | 0.07 | -3.45 | 0.18 | 0.81 | 3.12 | 1.25 | 1.89 | 2.71 | 4.99 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
| Shh. Funds | 51 | 49 | 49 | 50 | 51 | 50 | 51 | 53 | 55 | 58 | |
| Non Curr. Liab. | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
| Curr. Liab. | 7 | 6 | 5 | 4 | 7 | 6 | 6 | 6 | 6 | 5 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 59 | 56 | 55 | 55 | 57 | 56 | 57 | 58 | 61 | 63 | |
| Non Curr. Assets | 52 | 51 | 48 | 48 | 49 | 49 | 47 | 45 | 48 | 48 | |
| Curr. Assets | 7 | 5 | 6 | 7 | 8 | 7 | 11 | 14 | 13 | 15 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 59 | 56 | 55 | 55 | 57 | 56 | 57 | 58 | 61 | 63 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
| Net Sales | 29 | 30 | 31 | 34 | 38 | 38 | 41 | 32 | 39 | 47 | |
| Other Income | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Total Income | 29 | 30 | 32 | 35 | 39 | 39 | 41 | 33 | 40 | 48 | |
| Total Expenditure | -26 | -29 | -28 | -31 | -34 | -35 | -37 | -29 | -33 | -39 | |
| PBIDT | 3 | 2 | 4 | 4 | 5 | 4 | 5 | 4 | 7 | 9 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | -3 | -4 | -4 | -3 | -3 | -3 | -3 | -2 | -3 | -3 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -2 | |
| Exceptional Items | 0 | 0 | 0 | 0 | -1 | 0 | 0 | ||||
| PAT | 0 | -2 | 0 | 0 | 2 | 1 | 1 | 2 | 3 | 4 | |
| Adjusted EPS | 0 | -1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 2 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 4 | 4 | 2 | 3 | 3 | 6 | 4 | 5 | 3 | 4 | |
| Cash Fr. Inv. | -1 | -5 | -5 | -1 | -1 | -4 | -4 | -1 | 0 | -4 | |
| Cash Fr. Finan. | 0 | -1 | 2 | -1 | 0 | -2 | -1 | 0 | 0 | -2 | |
| Net Change | 2 | -1 | 0 | 2 | 2 | 0 | -1 | 4 | 3 | -1 | |
| Cash & Cash Eqvt | 2 | 1 | 1 | 2 | 3 | 4 | 3 | 7 | 10 | 9 |
|
Fri, 26 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed herewith the copy of Newspaper Advertisement published on May 25 2023 in Tamil Murasu (Coimbatore Edition) and May 26 2023 in Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on May 24 2023 |
|
Thu, 25 May 2023
Annual Secretarial Compliance Report For The Financial Year Ended 31St March 2023 Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we are submitting herewith the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March 2023 duly issued by M/s. Eswaramoorthy and company Practicing Company Secretaries Coimbatore. |
|
Wed, 24 May 2023
Board Meeting Outcome for Outcome Of Board Meeting In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held on May 24 2023 has transacted the following business: 1) Approved audited standalone results for the quarter and period ended March 31st 2023;2) Recommended the payment of 0.50 per equity share as Final Dividend for the financial year 2022-23 subject to approval of shareholders in the Annual General Meeting. |
| Mon, 05 Jun 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Equities
M.F.
Sectors
StockEdge Social